- Home
- TWN vs ARCT Comparison
TWN vs ARCT Comparison
Compare TWN & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWN
- ARCT
- Stock Information
- Founded
- TWN 1986
- ARCT 2013
- Country
- TWN Hong Kong
- ARCT United States
- Employees
- TWN N/A
- ARCT N/A
- Industry
- TWN Trusts Except Educational Religious and Charitable
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- TWN Finance
- ARCT Health Care
- Exchange
- TWN Nasdaq
- ARCT Nasdaq
- Market Cap
- TWN 346.7M
- ARCT 320.8M
- IPO Year
- TWN N/A
- ARCT N/A
- Fundamental
- Price
- TWN N/A
- ARCT $21.20
- Analyst Decision
- TWN
- ARCT Strong Buy
- Analyst Count
- TWN 0
- ARCT 9
- Target Price
- TWN N/A
- ARCT $50.88
- AVG Volume (30 Days)
- TWN 20.1K
- ARCT 850.2K
- Earning Date
- TWN 01-01-0001
- ARCT 11-06-2025
- Dividend Yield
- TWN 1.10%
- ARCT N/A
- EPS Growth
- TWN N/A
- ARCT N/A
- EPS
- TWN N/A
- ARCT N/A
- Revenue
- TWN N/A
- ARCT $122,122,000.00
- Revenue This Year
- TWN N/A
- ARCT N/A
- Revenue Next Year
- TWN N/A
- ARCT $28.92
- P/E Ratio
- TWN N/A
- ARCT N/A
- Revenue Growth
- TWN N/A
- ARCT N/A
- 52 Week Low
- TWN $25.22
- ARCT $8.04
- 52 Week High
- TWN $41.51
- ARCT $23.85
- Technical
- Relative Strength Index (RSI)
- TWN 60.69
- ARCT 54.94
- Support Level
- TWN $54.22
- ARCT $20.21
- Resistance Level
- TWN $57.01
- ARCT $23.60
- Average True Range (ATR)
- TWN 1.53
- ARCT 1.64
- MACD
- TWN -0.16
- ARCT -0.07
- Stochastic Oscillator
- TWN 52.37
- ARCT 44.74
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.